Investigate the Hepatitis B Drug Pipeline With New Report
Posted on: Wednesday, 12 September 2007, 09:02 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68211) has announced the addition of Infections - Hepatitis B Drug Pipeline Report to their offering.
"Infections - Hepatitis B Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of hepatitis b drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Hepatitis B Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Hepatitis B Projects
--Top 20 companies in early stage Hepatitis B Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68211
Source: Life Science Analytics
Fax: +353 1 4100 980
Source: Business Wire
Related Articles
- Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
- Lightwave Logic Retains Perdix Inc. to Identify and Develop Specific Products for Our Unique High Growth Market segments for Lightwave's 'Next Generation Electro-Optical Material Platform'
- Gain a Unique Insight into Top Companies in Early Stage Hepatitis C Projects
- Heartland Oil and Gas Continues Production Enhancement and Well and Pipeline Expansion Projects in Texas and Kansas
- Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
- Infections - Hepatitis C Drug Pipeline Report Provides Detail on Top 20 Companies With Products in the Early and Late Stage of Development
- University of Maryland Announces 28 Research Projects to Help Maryland Companies Develop Commercial Products: Projects Worth $5.2 Million
- Human Genome Sciences Announces Phase 3 Clinical Development Program for Albuferon(TM) in Chronic Hepatitis C
- Deltek WelcomRisk Receives Software Development Jolt Product Excellence Award
- China Health Holding Launches -- TAOIST Product Line - Phase III - Natural Herbal Product for OBESITY; Company's Products to Build on Successes of Traditional Chinese Medicine
 |
 |
User Comments (0)
RSS Feeds